Patient Blood Management Global Market Expected to Witness $19.07 Billion with Impressive Growth at a 6.4% CAGR By 2028 | Terumo Corporation, Immucor Inc., Macopharma, bioMérieux SA, Hitachi Ltd.

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Patient Blood Management Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The patient blood management market size has grown strongly in recent years. It will grow from $13.83 billion in 2023 to $14.86 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing number of surgical procedures, government initiatives, increasing demand for bloodless surgery, rising availability of blood substitutes, rising demand for quality healthcare.

The patient blood management market size is expected to see strongly grown in the next few years. It will grow to $19.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to aging population, growing demand for blood, changing demographics, increasing focus on personalized medicine, growing demand for safe and effective blood transfusions, increasing healthcare spending. Major trends in the forecast period include patient-centered care, data-driven decision-making, hemoglobin optimization, collaborative care, expanded use of autologous blood.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3240&type=smp

Market Segmentation:
The patient blood management market covered in this report is segmented -
1) By Product: Instruments, Accessories, Reagents And Kits, Softwares
2) By Component: Plasma, Whole Blood, Red Blood Cells
3) By Application: Hospital, Clinic, Other Applications

Major Driver - Global Patient Blood Management Market Thrives On The Rising Demand From Accidents, Trauma, And Surgical Procedures
The rising number of accidents, trauma cases, and surgical procedures contributed to the growth of the global patient blood management market. According to WHO, 1.35 million people die every year due to road accidents, and low-income and middle-income countries account for 93% of the fatalities occurring in the world due to road accidents. According to the Centers for Disease Control and Prevention, in 2021, the cesarean birth rate was 32.1% of all births. Increased number of accidents, trauma cases, and surgical procedures resulted in increased demand for blood, and its products are driving the market.

Competitive Landscape:
Major companies operating in the patient blood management market include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc, Abbott Laboratories, Grifols, Roche, LIVANOVA PLC, Danaher, Mediware information systems, Kawasumi Laboratories, Haier Biomedical, Diatron MI Zrt., BAG Diagnostics GmbH, Hitachi Ltd., Ortho Clinical Diagnostics, Beckman Coulter Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Nihon Kohden Corporation, Radiometer Medical ApS, Instrumentation Laboratory, F. Hoffmann-La Roche Ltd, Grifols Diagnostic Solutions Inc., HemoCue AB, Immucor GTI Diagnostics

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Top Trend - Hemasavr Is Enhancing Blood Collection And Transfusion Efficiency In Surgical Procedures
HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss. Clinicians can economically collect sterile, anticoagulated blood without any need for specialized resources. By this, the upfront shed blood collection cost decreases, and allogenic transfusions can be avoided with improved outcomes such as decreased patient mortality, low incidence of infections, and reduced risk of multi-organ failure.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Patient Blood Management Market Characteristics
3. Patient Blood Management Market Trends And Strategies
4. Patient Blood Management Market - Macro Economic Scenario
5. Patient Blood Management Market Size And Growth
…..
27. Patient Blood Management Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.